Basilea Pharmaceutica AG (SWX:BSLN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
50.40
+1.20 (2.44%)
Jun 6, 2025, 5:31 PM CET

Basilea Pharmaceutica AG Ratios and Metrics

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
618501423546485574
Upgrade
Market Cap Growth
18.52%18.52%-22.52%12.62%-15.59%14.12%
Upgrade
Enterprise Value
609551505636551662
Upgrade
Last Close Price
50.4041.3535.3045.8040.9253.15
Upgrade
PE Ratio
8.656.4640.4744.94--
Upgrade
Forward PE
12.4610.6315.1798.35--
Upgrade
PS Ratio
2.962.402.683.693.274.50
Upgrade
PB Ratio
7.636.19-42.28-26.35-8.27-5.63
Upgrade
P/TBV Ratio
7.676.22----
Upgrade
P/FCF Ratio
8.516.9031.48139.32--
Upgrade
P/OCF Ratio
8.316.7429.6977.36--
Upgrade
EV/Sales Ratio
2.922.643.204.313.725.19
Upgrade
EV/EBITDA Ratio
9.358.7221.7829.31154.82-
Upgrade
EV/EBIT Ratio
9.888.9323.0530.58183.33-
Upgrade
EV/FCF Ratio
8.397.5837.59162.43--
Upgrade
Debt / Equity Ratio
1.381.38-12.86-9.03-3.74-2.37
Upgrade
Debt / EBITDA Ratio
1.711.715.057.7641.61-
Upgrade
Debt / FCF Ratio
1.541.549.5747.76--
Upgrade
Asset Turnover
0.970.970.800.630.620.57
Upgrade
Inventory Turnover
3.993.994.134.185.336.11
Upgrade
Quick Ratio
3.933.932.481.961.223.87
Upgrade
Current Ratio
4.854.853.202.341.384.46
Upgrade
Return on Equity (ROE)
218.58%218.58%----
Upgrade
Return on Assets (ROA)
17.89%17.89%6.95%5.56%0.79%-5.93%
Upgrade
Return on Capital (ROIC)
24.78%24.78%9.61%7.96%1.25%-10.88%
Upgrade
Return on Capital Employed (ROCE)
29.10%29.10%17.40%14.30%4.10%-
Upgrade
Earnings Yield
12.55%15.48%2.47%2.23%-1.41%-2.56%
Upgrade
FCF Yield
11.75%14.50%3.18%0.72%-6.73%-9.74%
Upgrade
Buyback Yield / Dilution
-14.10%-14.10%-1.67%-2.24%-13.62%4.41%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.